Theme
Genomics '25: Gene Editing & Genetic Meds☆

CRSP-23.85%16.0%

NTLA-39.75%14.0%

BEAM-4.81%13.0%
SCTX-1.75%11.0%

PRME-54.65%9.0%

DTIL+19.28%8.0%

EDIT-33.42%8.0%

MGX-53.01%5.0%

SGMO0.00%5.0%

CRBU-43.05%4.0%

MGTX+26.19%4.0%

CLLS-58.19%3.0%
As of Oct 2, 2026, 9:55 PM ET
Genomics '25: Gene Editing & Genetic Meds Constituents
CRISPR Therapeutics AGCRSP | 16.0% | -0.02% | -6.06% | -2.57% | 0.03% | 5.75% | -7.79% | 62.20% | -23.85% | 23.45% | -50.19% | $5.35B |
Intellia Therapeutics, Inc.NTLA | 14.0% | 1.16% | -2.96% | -3.49% | 1.61% | 36.99% | -10.63% | 68.70% | -39.75% | -30.54% | -90.85% | $1.71B |
Beam Therapeutics Inc.BEAM | 13.0% | 0.45% | -6.05% | -16.83% | -0.12% | -12.12% | -14.41% | 31.82% | -4.81% | 6.80% | -71.64% | $2.52B |
Scribe Therapeutics Inc.SCTX | 11.0% | -2.24% | -39.88% | -45.39% | -1.75% | -1.75% | -1.75% | -1.75% | -1.75% | — | — | $271.7M |
Prime Medicine, Inc.PRME | 9.0% | -0.33% | -14.55% | -17.57% | 1.17% | -12.82% | -34.52% | 68.99% | -54.65% | -12.61% | -80.61% | $538.2M |
Editas Medicine, Inc.EDIT | 8.0% | 3.97% | -11.30% | -15.91% | 2.78% | 26.34% | 17.73% | 119.49% | -33.42% | -18.12% | -93.44% | $402.1M |
Precision BioSciences, Inc.DTIL | 8.0% | -0.32% | -10.08% | -13.22% | 2.13% | 55.41% | 53.93% | 37.85% | 19.28% | -33.79% | -98.20% | $174.2M |
Metagenomi, Inc. Common StockMGX | 5.0% | -7.69% | 2.63% | 0.86% | 5.88% | -27.78% | -23.03% | -12.03% | -53.01% | -50.24% | -93.20% | $38.4M |
Sangamo Therapeutics, Inc.SGMO | 5.0% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | $1.80B |
Caribou Biosciences, Inc.CRBU | 4.0% | 0.00% | -5.22% | -20.63% | 4.10% | -20.13% | -33.16% | 47.50% | -43.05% | -31.84% | -94.53% | $121.0M |
MeiraGTx Holdings plcMGTX | 4.0% | 1.22% | -14.17% | -24.61% | -0.56% | 33.33% | 40.21% | 66.67% | 26.19% | 163.17% | -18.93% | $999.3M |
Cellectis S.A.CLLS | 3.0% | 2.14% | -8.33% | -56.00% | 2.14% | -70.45% | -63.14% | 13.49% | -58.19% | -27.78% | -88.73% | $143.6M |
| Theme return | — | -0.04% | -10.47% | -16.11% | 0.45% | 16.12% | 0.52% | 93.85% | -14.18% | 23.90% | -67.22% | — |
| Average | 8.3% | -0.14% | -9.66% | -17.95% | 1.45% | 1.06% | -6.38% | 41.91% | -22.25% | -1.05% | -70.94% | $1.17B |
| Median | 8.0% | 0.00% | -7.19% | -16.37% | 1.39% | -0.87% | -9.21% | 42.68% | -28.63% | -18.12% | -88.73% | $470.2M |
| Std Dev | 4.2% | 2.70% | 10.40% | 16.84% | 2.05% | 32.55% | 31.02% | 36.54% | 28.05% | 55.66% | 32.02% | $1.48B |
| Min | 3.0% | -7.69% | -39.88% | -56.00% | -1.75% | -70.45% | -63.14% | -12.03% | -58.19% | -50.24% | -98.20% | $38.4M |
| Max | 16.0% | 3.97% | 2.63% | 0.86% | 5.88% | 55.41% | 53.93% | 119.49% | 26.19% | 163.17% | 0.00% | $5.35B |
| % Positive Tickers | 41.67% | 8.33% | 8.33% | 66.67% | 41.67% | 25.00% | 75.00% | 16.67% | 27.27% | 0.00% |